Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes

被引：0
|
作者：
Tasyurek, H. [1 ]
Eksi, Y. E. [2 ]
Sanlioglu, A. D. [2 ]
Balci, M. K. [2 ]
Sanlioglu, S. [1 ]
机构：
[1] Akdeniz Univ Hosp, Human Gene & Cell Therapy Ctr, TR-07058 Antalya, Turkey
[2] Akdeniz Univ, Fac Med, Dept Internal Med, Div Endocrinol & Metab, TR-07058 Antalya, Turkey
来源：
HUMAN GENE THERAPY | 2014年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P094
引用
收藏
页码：A86 / A86
页数：1
相关论文
共 50 条
  • [1] HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes
    Tasyurek, Hale M.
    Eksi, Yunus E.
    Sanlioglu, Ahter D.
    Altunbas, Hasan A.
    Balci, Mustafa K.
    Griffith, Thomas S.
    Sanlioglu, Salih
    GENE THERAPY, 2018, 25 (04) : 269 - 283
  • [2] HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes
    Hale M. Tasyurek
    Yunus E. Eksi
    Ahter D. Sanlioglu
    Hasan A. Altunbas
    Mustafa K. Balci
    Thomas S. Griffith
    Salih Sanlioglu
    Gene Therapy, 2018, 25 : 269 - 283
  • [3] Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
    Tasyurek, H. M.
    Altunbas, H. A.
    Canatan, H.
    Sanlioglu, S.
    HUMAN GENE THERAPY, 2015, 26 (10) : A98 - A98
  • [4] Potential Therapeutic Role of Vasoactive Intestinal Peptide in Diabetes
    Sanlioglu, Ahter Dilsad
    Karacay, Bahri
    Balci, Mustafa Kemal
    Griffith, Thomas S.
    Sanlioglu, Salih
    HUMAN GENE THERAPY, 2012, 23 (10) : A150 - A150
  • [5] Therapeutic Efficacy of Stable Analogues of Vasoactive Intestinal Peptide against Pathogens
    Campos-Salinas, Jenny
    Cavazzuti, Antonio
    O'Valle, Francisco
    Forte-Lago, Irene
    Caro, Marta
    Beverley, Stephen M.
    Delgado, Mario
    Gonzalez-Rey, Elena
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (21) : 14583 - 14599
  • [6] Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes
    Tasyurek, Hale M.
    Altunbas, Hasan Ali
    Balci, Mustafa Kemal
    Griffith, Thomas S.
    Sanlioglu, Salih
    HUMAN GENE THERAPY, 2018, 29 (07) : 802 - 815
  • [7] Gene transfer to human trabecular meshwork cells in vitro and ex vivo using HIV-based lentivirus
    Yan Xiang
    Bin Li
    Jun-Ming Wang
    Gui-Gang Li
    Hong Zhang
    Anne Manyande
    Xue-Bi Tian
    International Journal of Ophthalmology, 2014, (06) : 924 - 929
  • [8] Gene transfer to human trabecular meshwork cells in vitro and ex vivo using HIV-based lentivirus
    Xiang, Yan
    Li, Bin
    Wang, Jun-Ming
    Li, Gui-Gang
    Zhang, Hong
    Manyande, Anne
    Tian, Xue-Bi
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (06) : 924 - 929
  • [9] Preclinical Development of a HIV-Based Gene Therapeutic for Cystic Fibrosis Pulmonary Disease
    Limberis, Maria P.
    HUMAN GENE THERAPY, 2021, 32 (15-16) : 862 - 863
  • [10] Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation
    Sun, Guo-Ying
    Yang, Hui-Hui
    Guan, Xin-Xin
    Zhong, Wen-Jing
    Liu, Yong-Ping
    Du, Ming-Yuan
    Luo, Xiao-Qin
    Zhou, Yong
    Guan, Cha-Xiang
    MOLECULAR IMMUNOLOGY, 2018, 97 : 8 - 15
12345